Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vitamin B12 analog
|
| gptkbp:ATCCode |
B03BA03
|
| gptkbp:CASNumber |
13422-51-0
|
| gptkbp:chemicalFormula |
C62H89CoN13O15P
|
| gptkbp:color |
red
|
| gptkbp:discoveredBy |
Ernst Lester Smith
|
| gptkbp:discoveredIn |
1948
|
| gptkbp:eliminationHalfLife |
6 days
|
| gptkbp:form |
cobalamin
|
| https://www.w3.org/2000/01/rdf-schema#label |
hydroxycobalamin
|
| gptkbp:isAntidoteFor |
cyanide poisoning
|
| gptkbp:isApprovedDrug |
gptkb:World_Health_Organization
|
| gptkbp:isSolubleIn |
gptkb:water
|
| gptkbp:isVitamin |
B12
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:molecularWeight |
1346.37 g/mol
|
| gptkbp:pregnancyCategory |
A (Australia)
|
| gptkbp:PubChem_CID |
162146
DB00200 |
| gptkbp:routeOfAdministration |
intramuscular
intravenous |
| gptkbp:sideEffect |
allergic reactions
red discoloration of urine |
| gptkbp:UNII |
Q40Q9N063P
|
| gptkbp:usedFor |
cyanide poisoning
vitamin B12 deficiency |
| gptkbp:bfsParent |
gptkb:Hydroxocobalamin
|
| gptkbp:bfsLayer |
6
|